Temporal discounting in addiction

Temporal discounting in addiction describes the sharp narrowing of the future that Warren Bickel measured in opioid users: whereas the average nonaddicted person perceived a future extending 4.7 years ahead, the addicted user’s horizon was just nine days. In the book, that contrast gives scientific form to addiction’s displacement of other priorities. It also raises a practical question: whether helping people imagine and act toward a more distant future can make them less vulnerable to addiction or better able to recover.

The Compressed Future

Bickel’s comparison concerns more than planning far ahead. The surrounding account describes a hierarchy in which the drug can eclipse love, family, sex, and shelter. Against that pressure, a future measured in days rather than years helps explain why distant consequences may lose force beside the immediate demands of opioid use. The comparison is an average, not a description of every person with addiction, but its scale makes temporal discounting legible as a consequential pattern rather than a vague impression of short-sightedness.

The book places this measure alongside the experience of families and people caught between treatment, relapse, and criminal justice. When reporting on heroin’s arrival in Roanoke, Virginia, the author initially found that many families were too ashamed to speak publicly. In 2012, there were not yet Facebook groups connecting parents across the state to share rehabilitation advice, coping strategies, or practical support. These circumstances do not establish that temporal discounting caused family silence or isolation; instead, they show the social conditions around the people whose behavior research seeks to understand.

Bickel’s Prevention Ambition

In a 2016 interview, Bickel described a goal that extended beyond explaining addiction. He hoped to develop methods that could predict future addictive behavior among children and help those at risk improve and lengthen their temporal views, thereby giving them a stronger defense against addiction. The proposal treats a person’s orientation toward the future as something that might be assessed and strengthened, not merely as a fixed consequence of drug use.

The aspiration sits beside the limits of translation from research to lived experience. Bickel had received prestigious grants and awards for his work, yet the book’s reporter struggled to see how the research applied to heroin users nearby, including people trading sex for drug money a few blocks from his office. The question of whether an app designed by Bickel could have prevented Jesse Bolstridge’s death makes that gap personal without claiming that an app would have changed the outcome. Bickel responded by pointing to a framed proverb that expressed the value of taking constructive action even in darkness; the larger question of what could offer hope remained unresolved.

The Distance Between Insight and Care

The book’s treatment stories show why a longer temporal horizon, even if attainable, would not by itself remove barriers to recovery. Kristi Fernandez took Jesse back after he was dismissed from treatment, despite counselors advising against it, because she would not leave her eighteen-year-old son in another state without a place to live. She could not afford another expensive rehabilitation stay or the travel needed to ensure a transfer. An earlier ten-week program in Jacksonville had included medical detox and a brief period on buprenorphine, but Jesse was weaned off the medication after three weeks and still owed $25,000, despite insurance coverage and weekly payments from his checking account.

Tess Henry’s experience makes the financial and institutional obstacles equally concrete. While pregnant, she entered the Life Center of Galax, one of the few Virginia facilities that accepted patients receiving medication-assisted treatment. Later, buprenorphine helped her feel normal and was mostly covered by insurance, but appointments with her addiction doctor were cash-only: $700 up front, followed by $90 to $100 per visit, potentially four times a month. Her mother, Patricia Mehrmann, also described waiting lists for treatment. These accounts locate recovery not only in a person’s capacity to value the future but in whether care is affordable, available, and continuous.

Research and Its Limits in Practice

Bickel’s work later included a $1 million grant to pilot new protocols connecting emergency-room overdose patients directly to outpatient buprenorphine through Sublocade, a newly approved once-monthly injection. The book describes this as a separate practical strand of his addiction research, not as proof that the temporal-horizon proposal itself had been implemented. The contrast matters: a theory about future-oriented behavior and a system for transferring patients into treatment address different parts of a crisis, and neither guarantees that patients can remain in care.

The wider account repeatedly exposes the distance between possible treatment and effective access. Volunteers in Roanoke’s Hope Initiative assembled a five-page spreadsheet of thirty-six rehabilitation and aftercare providers, matching referrals to patients’ finances and available beds. Some volunteers helped arrange outpatient medication-assisted treatment, although they disagreed over its use even where scientific evidence supported it. In meetings, Tess encountered stigma because some participants regarded buprenorphine as incompatible with being clean; members asked to mentor her declined. At a local school-board presentation, Janine Underwood described silence in response to her account of the crisis, and the board declined to support the prevention program she sought to advance.

The book therefore gives temporal discounting explanatory force without allowing it to become a complete account of addiction. Bickel’s nine-day measure clarifies the contraction of the future under addiction and his hope of extending that horizon points toward prevention. But the stories around the research show that the future also depends on the structures people must navigate: treatment costs, limited provider capacity, interrupted medication, stigma, and institutions that fail to coordinate. The distance between a nine-day horizon and a more durable recovery is not simply a matter of individual decision-making; it is also a distance the systems of care must help people cross.